The y-aminobutyrate/benzodiazepine-receptor complex has been purified from a Triton X-100 extract of crude synaptic membranes from pig cerebral cortex and cerebellum by a combination of affinity and ion-exchange chromatography. 3-[(3-cholamidopropyl)dimethylammonio]propanesulphonate the same major polypeptide components (Mr 49000 and 55000) were isolated, but the receptor now retained its ability to be modulated by secobarbital and by the anaesthetic propanidid.
INTRODUCTION
y-Aminobutyrate (GABA) is the principal inhibitory neurotransmitter in the mammalian central nervous system. A major class of GABA receptors are associated with Cl-ion channels which constitute part of a protein complex containing 'receptor' sites for GABA, benzodiazepines, picrotoxinin and barbiturates (Olsen, 1981; Turner & Whittle, 1983) . Recently, there have been several reports describing the purification of solubilized GABA/benzodiazepine receptors by affinity chromatography using benzodiazepines as immobilized ligands (Martini et al., 1983; Sigel et al., 1983; Sigel & Barnard, 1984; Taguchi & Kuriyama, 1984) . Although, in all reports, GABA-and benzodiazepine-receptor-binding activities were found to co-purify, different preparations have displayed differences in subunit composition and ratio of ligand binding sites. In addition, some of the characteristic interactions between the recognition sites of the membrane-bound receptor complex have been reported to be retained after extraction and purification in media containing Triton X-100 (Martini et al., 1983) and Chaps (Sigel & Barnard, 1984) , but not deoxycholate/ Triton X-100 (Sigel et al., 1983) . It would appear, therefore, that the nature of the detergent used during isolation is of critical importance to the binding characteristics of the purified receptor complex. In this respect, the ability of barbiturates to modulate ligand binding to the receptor complex appears to be particularly sensitive to the nature of the detergent used for solubilization.
Stimulation by barbiturates of solubilized GABA and benzodiazepine receptor binding has been demonstrated only after extraction of membranes with Chaps . GABA receptor binding to a Chaps-solubilized preparation is also enhanced by the anaesthetic propanidid [the preceding paper (Kirkness & Turner, 1986) ]. When theGABA/benzodiazepine receptor was purified in the presence of Chaps, pentobarbital caused a weak stimulation of benzodiazepine binding, although an effect on GABA receptor binding was not reported (Sigel & Barnard, 1984) .
Although early studies indicated central-type benzodiazepine receptors existed in brain as an homogeneous population (Squires & Braestrup, 1977) , more recent evidence obtained from ligand-displacement studies Nielsen & Braestrup, 1980) and analysis by photoaffinity labelling (Sieghart & Karobath, 1980) has suggested the possibility of receptor subtypes. The evidence supporting receptor heterogeneity can be demonstrated in tissue from several brain regions, including cortex and hippocampus, but not from cerebellum. In the present paper we compare characteristics of the GABA/benzodiazepine receptor complex isolated from both pig cerebral cortex and cerebellum after solubilization and purification in the presence of Triton X-100. We (Amersham, Bucks., U.K.), adipic acid dihydrazideagarose, Chaps, L-a-lecithin (phosphatidylcholine), muscimol and secobarbital were from Sigma (Poole, Dorset, U.K.). All other materials were purchased from BDH, Poole, Dorset, U.K. Propanidid and chlorazepate were gifts from, respectively, Bayer U.K. Ltd. and Boehringer-Ingelheim (U.K.); other benzodiazepine compounds were donated by Hoffman-La Roche (Basel, Switzerland). Preparation of solubilized receptor Pig brain was obtained fresh from a slaughterhouse and the cortex or cerebellum removed, frozen and stored at -70°C until use. Soluble receptor was prepared essentially as described previously (Sigel & Barnard, 1984) with the following alterations. Washed membranes were solubilized in 2% Triton X-100, 5 mM-Chaps or 25 mM-Chaps/0.2% L-a-lecithin instead of the detergent used in the previous procedure. The membrane suspension was stirred with detergent for 30 min at 4°C before centrifugation at 140000 g for 1 h. The solubilized receptor was prepared in media containing the proteinase inhibitors EDTA (1 mM), benzamidine (1 mM), phenylmethanesulphonyl fluoride (0.3 mM), bacitracin (100 mg/litre) and trypsin inhibitors type 1I-S and 11-0 (10 mg/litre; Sigma). Isolation of the receptor complex Affinity chromatography and ion-exchange chromatography were performed essentially as described previously (Sigel et al., 1983) , with the following changes. After application ofthe Triton X-100-solubilized receptor complex to the affinity column, the column was washed at 50 ml/h with 10 mM-potassium phosphate (pH 7.4)/ 250 mM-KCl/2 mM-magnesium acetate/0. 1 mM-EGTA/ 10% (w/v) sucrose/0.2% (w/v) Triton X-100 (800 ml). All other steps were as previously described. Receptor preparations solubilized with 5 mM-Chaps or 25 mMChaps/0.2% L-a-lecithin were purified identically, except that in all media used during purification, Triton X-100 was replaced by 5 mM-Chaps or 5 mM-Chaps/0.05% L-a-lecithin respectively. Binding assays Ligand binding to the solubilized receptor complex was measured by a PEG precipitation/sedimentation assay (Bensadoun & Weinstein, 1976) . Photoaffinity labelling Photoaffinity labelling of the receptor complex was performed by the method of Mohler et al. (1980) aliquot of 24% (w/v) trichloroacetic acid was added, followed by incubation for 30 min at 0 'C and centrifugation at 11000 g for 10 min. The pellet was washed twice with acetone (250 ,ul) and subjected to SDS/polyacrylamide-gel electrophoresis as described below. A control experiment included flunitrazepam (30 /tM) before addition of [3H]flunitrazepam. After SDS/polyacrylamide-gel electrophoresis, gels were treated with PPO (Skinner & Griswold, 1983) , dried and subjected to fluorography at -70 'C on Fuji RX film for 7 days.
SDS/polyacrylamide-gel electrophoresis
Samples were concentrated by precipitation in 12% (w/v) trichloroacetic acid and washed twice with acetone. Precipitated protein was dissolved in sample buffer containing 60 mM-Tris/HCI, pH 6.8, 2% (w/v) SDS, 100% (w/v) glycerol, 10 mM-dithiothreitol and 0.01 % (w/v) Bromophenol Blue, and heated for 2 min at 100 'C. SDS/polyacrylamide-gel electrophoresis was performed with 1 mm-thick gels by using the system of Laemmli (1970) with a 7-17% -(w/v)-polyacrylamide gradient. Gels were silver-stained by a modification of the method of Morrisey (1981) as described by Sigel & Barnard (1984) .
RESULTS

Purification of the GABA/benzodiazepine-receptor complex
The GABA/benzodiazepine-receptor complex was purified from a Triton X-100 extract of crude synaptic membranes of pig cerebral cortex by affinity and ion-exchange ch-romatography. t Before binding assay, soluble receptor (0.5 ml) was dialysed against 20 mM-potassium phosphate (pH 7.4)/0.1 mM-EDTA/0.5%
Triton X-100/0.02% NaN3 (500 ml). (Fig. 2a) . When labelled irreversibly with [3H]flunitrazepam after u.v. illumination \ (Fig. 2c) , radioactivity was incorporated predominantly !0 * into the Mr-49000 polypeptide, although some radioactivity was also detectable in the Mr-55000 band. The receptor complex purified from cerebellum displayed a 5 -similar polypeptide pattern (Fig. 2b) to that derived from cortex and incorporated radioactivity predominantly into 0 the MrA49000 polypeptide (Fig. 2d) Purification of the receptor complex in the presence of Chaps Solubilization of GABA-receptor binding activity which retained optimal sensitivity to stimulation by Vol. 233 Table 2 . Binding properties of the Triton X-100 purified GABA/benzodiazepine-receptor complex Binding of ligands to the crude solubilized receptor was measured after dialysis as described in the footnote to Table 1 . Binding coefficients were determined from Scatchard plots, with experimental details as described in the legend to Fig. 1 barbiturates and the anaesthetic propanidid was found after treatment ofmembranes with low concentrations of Chaps [the preceding paper (Kirkness & Turner, 1985) ]. The GABA/benzodiazepine receptor was purified essentially as before, but with 5 mM-Chaps replacing Triton X-100 in all stages. The yield of purified receptor protein obtained by this procedure was reduced to 25% ofthat obtained before (Table 3) . This was principally due to the low solubilizing power of 5 mM-Chaps. When membranes were solubilized with 25 mM-Chaps/0.2% L-a-lecithin and subsequently purified in the presence of 5 mM-Chaps/0.05 % L-a-lecithin, the yield increased to between 50 and 60% of that obtained by extraction and purification in the presence of Triton X-100. Table 3 also shows differences in the characteristics of ligand binding to the receptor complex extracted by the two detergents. At the concentration of ligand examined, the ratio of [3H]muscimol to [3H]flunitrazepam specific binding activity was in the range 1.9-2.8 (ten preparations) after extraction with Triton X-100, and 0.3-0.6 (four preparations) after extraction with Chaps. Similar ratios were found after purification of the receptor complex. This decreased ratio, after extraction with Chaps, resulted principally from a substantial decrease in [3H]muscimol specific binding activity.
Stimulation of ligand binding to the Chaps-purified receptor complex
As shown in Fig. 3 , propanidid caused a concentrationdependent stimulation of [3H]muscimol binding to the Chaps-purified receptor complex. Binding was stimulated to a maximum of 138 % of control binding at the highest concentration of propanidid examined (5 mM).
Secobarbital at 1 mm also caused a stimulation of [3H]muscimol binding to the Chaps-purified preparation (128%). In addition, the binding of 1 nM-[3H]flunitrazepam to this preparation was stimulated by 1 mmsecobarbital (118%) and 0.1 mM-GABA (125%). Assay conditions were as described in the legend to Fig. 3 . The extent to which binding to the purified receptor was stimulated was not affected by the concentration ofChaps (5 or 25 mM) used to extract the receptor from the membrane.
In agreement with a previous report (Sigel & Barnard, 1984) , we found that SDS/polyacrylamide-gel electrophoresis of the Chaps-purified receptor produced a polypeptide pattern similar to that isolated in media containing Triton X-100, with only two major bands, at Mr 49000 and 55000 (results not shown). 
DISCUSSION
Solubilization of membrane-bound receptors is a major problem associated with their purification, as the Table 1. t As *, but substituting 5 mM-Chaps for 0.5% (w/v) Triton X-100 in dialysis buffer.
t As *, but substituting 5 mM-Chaps/0.05% L-ac-lecithin for 0.5% (w/v) Triton X-100 in dialysis buffer. and of two types of benzodiazepine receptor (Lo et al., 1982) has been reported after treatment of brain membranes with Triton X-100. These properties could explain the differences in ligand-binding characteristics and subunit composition reported for the GABA/ benzodiazepine-receptor complex isolated from Triton X-100 extracts (Martini et al., 1983) and from sodium deoxycholate extracts (Sigel et al., 1983) .
In the present study, (3.5-3.8 ). This higher value may result from the greater instability of benzodiazepine binding in the presence of sodium deoxycholate . The receptor complex from rat brain extracted and isolated in Triton X-100 was reported to contain only one subunit, of Mr 60000 (Martini et al., 1983) . More recent reports suggest that the receptor is comprised of two polypeptides, of Mr 53000 and 57000 (bovine and rat brain ; Sigel et al., 1983; Sigel & Barnard, 1984) or Mr 48500 and 54500 (rat brain; Taguchi & Kuriyama, 1984) . We have also observed two major bands (Mr 49000 and 55000) after SDS/polyacrylamide-gel electrophoresis of the receptor purified from pig cortex or cerebellum. The Mr-55000 band appeared slightly diffuse and may represent a doublet.
Photoaffinity labelling of the receptor complex purified from cortex resulted in predominant incorporation of radioactivity into the Mr-49 000 band, although some radioactivity was also detectable in the Mr-55000 polypeptide. A similar distribution was reported after labelling ofthe receptor purified from bovine cortex (Sigel et al., 1983) . In contrast, no radioactivity was incorporated into the Mr-55 000 band from cerebellum, although traces were detected at MrA43 000, corresponding to a band that stained weakly for protein (Fig. 2d ). Although this difference in labelling may result from differential proteolytic action on the receptor preparations from the two brain regions, it is consistent with several lines of evidence suggesting heterogeneity in central-type benzodiazepine receptors. The triazolopyridazine CL218872 can interact with benzodiazepine receptors in a number of brain regions, in a manner suggesting receptor heterogeneity or negative cooperativity (Squires et al., 1979; Klepner et al., 1979) . From these studies, multiple benzodiazepine receptors were predicted in cortex and hippocampus, but not cerebellum. Corresponding results have been obtained from experiments employing photoaffinity labelling of membrane-bound benzodiazepine receptors. By using membrane preparations from cerebellum, [3H]flunitrazepam was irreversibly incorporated into a single polypeptide (Mr 51 000), whereas in other brain areas, additional polypeptides (Mr 53000, 55000 and 57000) were also labelled (Sieghart & Karobath, 1980; Sieghart & Drexler, 1983) . We have shown that this characteristic is retained in purified preparations of receptor. The difference in labelling of the purified receptor from cortex and cerebellium may result from heterogeneity in the Mr-55000 subunits. Alternatively, regional differences in receptor conformation may permit non-specific labelling of the Mr-55000 band in cortex but not in cerebellum.
The ability of barbiturates and propanidid to stimulate solubilized [3H]muscimol-binding activity was found to be optimal after extraction from membranes with low concentrations of Chaps (Kirkness & Turner, 1986) .
[3H]Muscimol binding to the GABA/benzodiazepine receptor extracted and purified in the presence of 5 mM-Chaps retained its sensitivity to these anaesthetic agents. The extent ofmaximum enhancement is relatively low (135-140%) compared with the effect in crude solubilized and membrane preparations (Kirkness & Turner, 1986) , indicating partial inactivation of the effect during isolation. In agreement with Sigel & Barnard (1984) , [3H] flunitrazepam binding to a Chaps-purified receptor preparation was also weakly stimulated by secobarbital and GABA. Increasing the concentration of Chaps used to extract the receptor from the membranes to 25 mm approximately doubled the yield of purified receptor, but did not affect the ability of secobarbital and propanidid to enhance ligand binding. The relatively rapid exchange of 25 mM-Chaps for 5 mM-Chaps in the affinity column wash may prevent the apparent inhibitory effect of high Chaps concentrations on barbiturate sensitivity (Kirkness & Turner, 1986 (Table 3) . The Chaps-purified preparation displayed no differences in polypeptide composition from that of the preparation isolated in Triton X-100, indicating that the differences in [3H]muscimol binding and responsiveness to barbiturates (and propanidid) may result from differences in receptor conformation after isolation by the different procedures. Treatment of membranes with low concentrations of Triton X-100 has been shown to cause considerable activation of GABA receptor binding (Enna & Snyder, 1977; Chiu & Rosenburg, 1979) . In addition, studies with the purified receptor indicate that activation is caused by conversion of [3H]muscimol binding sites from low to high affinity (Sigel & Barnard, 1984) . Triton X-100 binds very tightly to proteins and may displace receptor-bound phospholipids that could play an important role in the interactions between the recognition sites of the receptor complex. A possible involvement of lipid components in the interactions is suggested by the observation that the potency of a series of barbiturates to enhance GABA (Whittle & Turner, 1982; Olsen & Snowman, 1982) and benzodiazepine (Leeb-Lundberg & Olsen, 1982) binding to membranes correlates well with their lipid solubility. Propanidid is also highly-lipid-soluble. The stereospecificity of the interaction of some barbiturates with receptor binding would, however, suggest that protein interactions may also be involved (Olsen & Snowman, 1982) .
By using a Chaps-purified receptor preparation, in which interactions between the various recognition sites can be demonstrated, it may be possible to obtain a better understanding of the molecular interactions underlying regulation at the GABA synapse. 
